Nebula Research & Development’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,929
Closed -$966K 735
2023
Q3
$966K Buy
+3,929
New +$1.08M 0.51% 6

Other funds holding HCA

Nebula Research & Development's HCA Position: Q4 2023 in Review

Nebula Research & Development sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 3,929 shares — an estimated $966K sold.

Nebula Research & Development first reported a position in HCA in Q3 2023 and held it in 1 quarter. The position peaked at $966K in Q3 2023. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Nebula Research & Development reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Nebula Research & Development sold 3,929 HCA Healthcare shares in Q4 2023, an estimated $966K.
  • Nebula Research & Development first reported a position in HCA Healthcare in Q3 2023 and held it in 1 quarter.
  • Nebula Research & Development's HCA Healthcare position peaked at $966K in Q3 2023.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.